Cost-Effectiveness of a Health Behavior Intervention for Type 2 Diabetes in Nepal
Author Information
Author(s): Padam Kanta Dahal, Zanfina Ademi, Lal Rawal, Mahumud Rashidul Alam, Grish Paudel, Biraj Karmacharya, Haruka Sakamoto, Tomohiko Sugishita, Corneel Vandelanotte
Primary Institution: Central Queensland University
Hypothesis
This study aimed to assess the within-trial economic evaluation of a health behaviour intervention compared with usual care for managing type 2 diabetes in a community setting in Nepal.
Conclusion
Health behaviour interventions in community settings are a cost-effective approach to manage type 2 diabetes, offering good value for money.
Supporting Evidence
- The intervention yielded an incremental cost of US $28.55 per person.
- The ICER associated with the health behaviour intervention was US $3,358.82 per QALY gained.
- The intervention was cost-effective at the threshold of US $4,140.
- Probabilistic sensitivity analysis indicated an 89.63% probability of cost-effectiveness.
- Participants in the intervention group had a QALY gain of 0.0085 compared to the control group.
Takeaway
This study shows that helping people change their habits can be a smart way to manage diabetes without spending too much money.
Methodology
A cluster randomised control trial was conducted with 30 clusters and 481 patients, comparing a health behaviour intervention to usual care over 6 months.
Potential Biases
Self-reported data may introduce reporting bias.
Limitations
The study relied on short-term follow-up and was limited to two specific geographical locations in Nepal, which may affect generalizability.
Participant Demographics
Adults aged 30–70 years with type 2 diabetes, with a mix of genders and various occupations.
Statistical Information
P-Value
0.0085
Confidence Interval
95% CI = US $21.26 to US $35.84
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website